New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 27, 2012
19:32 EDTMRVLMarvell has reasons for optimism in post-trial motions, Reuters says
Marvell Technologies (MRVL), which lost a jury verdict ordering the company to pay $1.17B to Carnegie Mellon in a patent lawsuit, has reasons for optimism in its appeals process, according to a Reuters report. The report notes that previous patent infringement rulings of the size handed down to Marvell did not hold up in appeals, and the report also cites a Santa Clara University School of Law professor who says patent damages law, "leaves parties leeway to argue for damages amounts that differ drastically, often by 100-fold and sometimes much more." Reference Link
News For MRVL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 21, 2014
10:19 EDTMRVLMarvell rises sharply after results, levels to watch
Subscribe for More Information
07:43 EDTMRVLMarvell outlook still positive, says RBC Capital
After Marvell reported lower than expected Q3 revenue, RBC Capital says that the revenue shortfall was caused by weakness in the company's least profitable business. The firm expects the company's wireless business to rebound in 1Q15, and it expects Marvell's payment to Carnegie Mellon to be reduced. It keeps a Top Pick rating on the shares.
November 20, 2014
16:10 EDTMRVLMarvell sees Q4 EPS 24c plus or minus 2c, consensus 26c
Sees Q4 revenue $880M-$900M, consensus $930.89M.
16:09 EDTMRVLMarvell reports Q3 EPS 29c, consensus 29c
Reports Q3 revenue $930.14M, consensus $976.14M.
15:28 EDTMRVLNotable companies reporting after market close
Subscribe for More Information
November 19, 2014
07:36 EDTMRVLMarvell volatility elevated into Q1 and outlook
Subscribe for More Information
November 14, 2014
16:52 EDTMRVLGreenlight Capital gives quarterly update on stakes
Subscribe for More Information
November 13, 2014
10:01 EDTMRVLOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: ATK (ATK) downgraded to Hold from Buy at Argus... Adeptus Health (ADPT) downgraded to Hold from Buy at Deutsche Bank... American Woodmark (AMWD) downgraded to Neutral from Buy at Longbow... Avnet (AVT) downgraded to Sell from Neutral at Goldman... Baxano Surgical (BAXS) downgraded to Sell from Buy at Summer Street... Beazer Homes (BZH) downgraded to Neutral from Overweight at JPMorgan... Bristol-Myers (BMY) downgraded to Equal Weight from Overweight at Morgan Stanley... Centene (CNC) downgraded to Market Perform from Outperform at FBR Capital... Cherry Hill Mortgage (CHMI) downgraded to Equal Weight from Overweight at Barclays... Discover (DFS) downgraded to Hold from Buy at Deutsche Bank... Fleetmatics (FLTX) downgraded to Neutral from Buy at BofA/Merrill... Gazprom (OGZPY) downgraded to Neutral from Overweight at JPMorgan... Jabil Circuit (JBL) downgraded to Neutral from Buy at Goldman... LabCorp (LH) downgraded to Hold from Buy at Deutsche Bank... Laredo Petroleum (LPI) downgraded at BMO Capital... Macy's (M) downgraded to Market Perform from Outperform at Wells Fargo... Madison Square Garden (MSG) downgraded to Equal Weight from Overweight at Morgan Stanley... Marvell (MRVL) downgraded to Sell from Neutral at Goldman... Meritor (MTOR) downgraded to Neutral from Overweight at Piper Jaffray... Swedbank (SWDBY) downgraded to Underperform from Sector Perform at RBC Capital... TransGlobe (TGA) downgraded to Sector Perform from Outperform at Scotia Capital... UIL Holdings (UIL) downgraded to Hold from Buy at Argus... Verint Systems (VRNT) downgraded to Fair Value from Buy at CRT Capital... ZAIS Financial (ZFC) downgraded to Equal Weight from Overweight at Barclays.
07:27 EDTMRVLMarvell volatility elevated into Q1 and outlook
Subscribe for More Information
05:28 EDTMRVLMarvell downgraded to Sell from Neutral at Goldman
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use